Active Health Foods, Inc. (AHFD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2020 | 2019 | 2013 | 2012 | 2011 | 2011 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 29.48 Thousand | 75.68 Thousand | - | - |
| Cost of Revenue | - | - | 31.65 Thousand | 62.69 Thousand | - | - |
| Gross Profit | - | - | -2172.00 | 12.98 Thousand | - | - |
| Operating Expenses | 6560.00 | 104.3 Thousand | 827.19 Thousand | 5.08 Million | 100.63 Thousand | 19.08 Thousand |
| Selling, General and Administrative Expenses | 6560.00 | 104.3 Thousand | 827.19 Thousand | 5.08 Million | 100.63 Thousand | 19.08 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 6560.00 | 104.3 Thousand | 858.84 Thousand | 5.15 Million | 100.63 Thousand | 19.08 Thousand |
| Operating Income | -6560.00 | -104.3 Thousand | -829.36 Thousand | -5.17 Million | -100.63 Thousand | -19.08 Thousand |
| Interest Expense | - | - | 418.24 Thousand | 5967.00 | - | - |
| Income Tax Expense | - | - | -411.12 Thousand | -95.37 Thousand | - | - |
| Earnings before Tax | -6560.00 | -104.3 Thousand | -1.36 Million | -5.22 Million | -100.63 Thousand | -19.08 Thousand |
| Net Income | -6560.00 | -104.3 Thousand | -1.36 Million | -5.22 Million | -100.63 Thousand | -19.08 Thousand |
| Earnings Per Share Basic | - | - | -2.33 | -7171.43 | -51.06 | -8.39 |
| Earnings Per Share Diluted | - | - | -2.33 | -7171.43 | -51.06 | -8.39 |
| Weighted Average Shares Outstanding | 6.56 Billion | 6.51 Billion | 584.18 Thousand | 729.00 | 1971.00 | 2275.00 |
| Weighted Average Shares Outstanding (Diluted) | 6.3 Billion | 6.3 Billion | 584.18 Thousand | 729.00 | 1971.00 | 2275.00 |
| Gross Margin | - | - | -0.07 | 0.17 | - | - |
| EBIT Margin | - | - | -28.13 | -67.08 | - | - |
| Profit Margin | - | - | -46.16 | -69.08 | - | - |
| EBITDA | - | - | -829.36 Thousand | -5.07 Million | -100.63 Thousand | -19.08 Thousand |
| Earnings Before Tax Margin | - | - | -28.13 | -68.42 | - | - |
| Breakdown | 2021 Q3 | 2020 Q4 | 2020 FY | 2020 Q3 | 2019 FY | 2014 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 22.58 Thousand |
| Cost of Revenue | - | - | - | - | - | 28.46 Thousand |
| Gross Profit | - | - | - | - | - | -5874.00 |
| Operating Expenses | 316.92 Thousand | 1640.00 | 6560.00 | 1640.00 | 104.3 Thousand | 340.09 Thousand |
| Selling, General and Administrative Expenses | 1640.00 | 1640.00 | - | 1640.00 | - | 340.09 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 316.92 Thousand | 1640.00 | 6560.00 | 1640.00 | 104.3 Thousand | 368.55 Thousand |
| Operating Income | -1640.00 | -1640.00 | -6560.00 | -1640.00 | -104.3 Thousand | -345.96 Thousand |
| Interest Expense | - | - | - | - | - | 46.13 Thousand |
| Income Tax Expense | -315.28 Thousand | - | - | - | - | -586.61 Thousand |
| Earnings before Tax | -316.92 Thousand | -1640.00 | -6560.00 | -1640.00 | -104.3 Thousand | -79.92 Thousand |
| Net Income | -316.92 Thousand | -1640.00 | -6560.00 | -1640.00 | -104.3 Thousand | -79.92 Thousand |
| Earnings Per Share Basic | - | - | - | - | - | -0.04 |
| Earnings Per Share Diluted | - | - | - | - | - | -0.04 |
| Weighted Average Shares Outstanding | 8.12 Billion | 6.3 Billion | 6.56 Billion | 6.3 Billion | 6.51 Billion | 2.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.94 Billion | 6.3 Billion | 6.3 Billion | 6.3 Billion | 6.3 Billion | 2.03 Million |
| Gross Margin | - | - | - | - | - | -0.26 |
| EBIT Margin | - | - | - | - | - | 12.70 |
| Profit Margin | - | - | - | - | - | -3.54 |
| EBITDA | -315.28 Thousand | - | - | - | - | 286.78 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | -15.32 |
605208
NYXO
1329
002999
4IG
QDMI